Carlson Capital’s Lantern Pharma LTRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-60,000
| Closed | -$257K | – | 137 |
|
|
2023
Q4 | $257K | Sell |
60,000
-35,000
| -37% | -$150K | 0.02% | 115 |
|
|
2023
Q3 | $324K | Hold |
95,000
| – | – | 0.03% | 124 |
|
|
2023
Q2 | $536K | Sell |
95,000
-29,900
| -24% | -$169K | 0.05% | 107 |
|
|
2023
Q1 | $603K | Sell |
124,900
-13,100
| -9% | -$63.3K | 0.06% | 103 |
|
|
2022
Q4 | $834K | Sell |
138,000
-30,000
| -18% | -$181K | 0.06% | 105 |
|
|
2022
Q3 | $803K | Sell |
168,000
-2,000
| -1% | -$9.56K | 0.06% | 104 |
|
|
2022
Q2 | $971K | Buy |
170,000
+2,700
| +2% | +$15.4K | 0.07% | 110 |
|
|
2022
Q1 | $1.2M | Buy |
167,300
+42,300
| +34% | +$302K | 0.08% | 138 |
|
|
2021
Q4 | $998K | Buy |
+125,000
| New | +$998K | 0.06% | 128 |
|